Re: Comments on “Chronic Migraine Is Associated With Region-Specific High-Grade Enlarged Perivascular Spaces: Retrospective Matched Case-Control Study”
Journal of Clinical Neurology · 2026 · 22 (6) · 733
DOI: 10.3988/jcn.2026.0433 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Neurology, 2026. Verfasst von Jae Wook Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea.
- Department of Neurology, Pusan National University School of Medicine, Busan, Korea.
- Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
- Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. bijoukim78@gmail.com.
ORCID-Profile: Jae Wook Cho, Gha-Hyun Lee, Jiyoung Kim
Zitieren
APA
Cho, J. W., Lee, G. H., & Kim, J. (2026). Re: Comments on “Chronic Migraine Is Associated With Region-Specific High-Grade Enlarged Perivascular Spaces: Retrospective Matched Case-Control Study”. Journal of Clinical Neurology, 22(6), 733. https://doi.org/10.3988/jcn.2026.0433
Vancouver
Cho JW, Lee GH, Kim J. Re: Comments on “Chronic Migraine Is Associated With Region-Specific High-Grade Enlarged Perivascular Spaces: Retrospective Matched Case-Control Study”. Journal of Clinical Neurology. 2026;22(6):733. doi:10.3988/jcn.2026.0433
BibTeX
@article{Cho2026,
author = {Cho, Jae Wook and Lee, Gha-Hyun and Kim, Jiyoung},
title = {Re: Comments on “Chronic Migraine Is Associated With Region-Specific High-Grade Enlarged Perivascular Spaces: Retrospective Matched Case-Control Study”},
journal = {Journal of Clinical Neurology},
year = {2026},
volume = {22},
number = {6},
pages = {733},
doi = {10.3988/jcn.2026.0433}
}
EUVIMED